2,568 Shares in Agilent Technologies, Inc. (NYSE:A) Acquired by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in Agilent Technologies, Inc. (NYSE:A) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,568 shares of the medical research company’s stock, valued at approximately $374,000.

Several other institutional investors and hedge funds have also bought and sold shares of A. Ballentine Partners LLC boosted its stake in Agilent Technologies by 2.5% in the 1st quarter. Ballentine Partners LLC now owns 2,963 shares of the medical research company’s stock worth $431,000 after purchasing an additional 73 shares in the last quarter. Haverford Trust Co grew its holdings in shares of Agilent Technologies by 1.7% during the first quarter. Haverford Trust Co now owns 4,423 shares of the medical research company’s stock valued at $644,000 after buying an additional 74 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its position in shares of Agilent Technologies by 3.2% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,421 shares of the medical research company’s stock valued at $337,000 after acquiring an additional 75 shares during the period. Carmel Capital Partners LLC raised its stake in Agilent Technologies by 1.2% in the 4th quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock worth $933,000 after acquiring an additional 78 shares during the last quarter. Finally, Monumental Financial Group Inc. lifted its position in Agilent Technologies by 0.9% during the 4th quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company’s stock worth $1,320,000 after acquiring an additional 89 shares during the period.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the transaction, the chief executive officer now directly owns 25,185 shares of the company’s stock, valued at $3,274,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the sale, the senior vice president now owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares of the company’s stock, valued at $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

Shares of NYSE A traded up $1.65 during midday trading on Wednesday, hitting $127.07. The stock had a trading volume of 1,826,510 shares, compared to its average volume of 1,789,323. The company has a quick ratio of 1.64, a current ratio of 2.15 and a debt-to-equity ratio of 0.34. The stock has a 50 day simple moving average of $138.00 and a 200-day simple moving average of $137.90. The company has a market capitalization of $37.07 billion, a PE ratio of 29.91, a P/E/G ratio of 4.28 and a beta of 1.05. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.03. The company had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm’s quarterly revenue was down 8.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.27 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on A shares. Citigroup upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $135.00 to $150.00 in a research note on Wednesday. Jefferies Financial Group restated a “hold” rating and set a $135.00 price objective (down from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. JPMorgan Chase & Co. cut their price objective on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Robert W. Baird decreased their target price on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research report on Thursday, May 30th. Finally, Evercore ISI lifted their price objective on Agilent Technologies from $126.00 to $130.00 and gave the company an “in-line” rating in a research note on Tuesday, July 2nd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $138.06.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.